Network pharmacology and in vivo evidence of the pharmacological mechanism of geniposide in the treatment of atherosclerosis

[1] Conte SM(2018)Peripheral arterial disease Heart Lung Circ. 27 427-432

[2] Vale PR(2017)Animal models of atherosclerosis Eur J Pharmacol 816 3-13

[3] Emini Veseli B(2011)Macrophages in the pathogenesis of atherosclerosis Cell 145 341-355

[4] Perrotta P(2018)Atherosclerosis Circ Res 123 1118-1120

[5] De Meyer GRA(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[6] Moore KJ(2023)Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation? Eur Heart J 44 1973-1975

[7] Tabas I(2021)Targeting cardiovascular inflammation: next steps in clinical translation Eur Heart J 42 113-131

[8] Kobiyama K(2006)Inflammation and atherosclerosis Annu Rev Pathol 1 297-329

[9] Ley K(2023)History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: role of inflammation and comorbidities Int J Cardiol 382 76-82

[10] Baigent C(2017)Enhancement of active compound, genipin, from gardeniae fructus using immobilized glycosyl hydrolase family 3 beta-glucosidase from lactobacillus antri AMB Express 7 64-5108

[1] Conte SM(2018)Peripheral arterial disease Heart Lung Circ. 27 427-432

[2] Vale PR(2017)Animal models of atherosclerosis Eur J Pharmacol 816 3-13

[3] Emini Veseli B(2011)Macrophages in the pathogenesis of atherosclerosis Cell 145 341-355

[4] Perrotta P(2018)Atherosclerosis Circ Res 123 1118-1120

[5] De Meyer GRA(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[6] Moore KJ(2023)Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation? Eur Heart J 44 1973-1975

[7] Tabas I(2021)Targeting cardiovascular inflammation: next steps in clinical translation Eur Heart J 42 113-131

[8] Kobiyama K(2006)Inflammation and atherosclerosis Annu Rev Pathol 1 297-329

[9] Ley K(2023)History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: role of inflammation and comorbidities Int J Cardiol 382 76-82

[10] Baigent C(2017)Enhancement of active compound, genipin, from gardeniae fructus using immobilized glycosyl hydrolase family 3 beta-glucosidase from lactobacillus antri AMB Express 7 64-5108